Fresenius Medical Care AG & Co. KGaA operates within the Kidney dialysis centers sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius Medical Care AG & Co. KGaA with three other health care providers in Europe: Orpea SA of France (2017 sales of 3.14 billion Euro [US$3.55 billion] ), Ramsay Generale De Sante SA of France (2.23 billion Euro [US$2.53 billion] of which 82% was Hospitals/Surgery), and Fresenius SE & Co KGaA (33.89 billion Euro [US$38.33 billion] of which 52% was Fresenius Medical Care).

Sales Analysis. During the year ended December of 2017, sales at Fresenius Medical Care AG & Co. KGaA were 17.78 billion Euro (US$20.12 billion). This is an increase of 9.6% versus 2016, when the company's sales were 16.23 billion Euro. This was the fifth consecutive year of sales increases at Fresenius Medical Care AG & Co. KGaA (and since 2012, sales have increased a total of 66%). Sales of Corporate / Eliminations saw an increase of 13.1% in 2017, from 13.04 million Euro to 14.75 million Euro.